Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)

Jiangxi Sanxin Medtec Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	281.94	264.94	227.4	206.63	184.63	155.91
Depreciation & Amortization	129.28	120.29	90.73	74.49	65.76	57.85
Other Amortization	4.4	2.39	0.36	3.77	5.75	3.35
Loss (Gain) From Sale of Assets	0.65	0.85	-0.19	-0.16	-0.01	0.89
Asset Writedown & Restructuring Costs	6.22	1.69	1.1	0.38	7.68	5.2
Loss (Gain) From Sale of Investments	-10.28	-10.64	0.78	-11.08	-4.63	-1.07
Provision & Write-off of Bad Debts	6.55	4.18	4.03	0.82	-	-
Other Operating Activities	33.92	32.39	24.83	22.37	17.78	18.23
Change in Accounts Receivable	-31	-19.47	28.52	-9.37	20.18	-33.42
Change in Inventory	-70.82	-11.15	3.33	-4.73	-40.59	-10.82
Change in Accounts Payable	75.68	68.75	10.09	48.95	117.15	125.01
Change in Other Net Operating Assets	4.33	11.74	7.84	8.32	24.7	9.81
Operating Cash Flow	426.9	460.6	389.59	339.81	402.18	329.72
Operating Cash Flow Growth	-3.55%	18.23%	14.65%	-15.51%	21.98%	20.82%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-231.51	-241.87	-217.54	-287.47	-210.55	-174.8
Sale of Property, Plant & Equipment	0.53	0.65	1.39	0.5	0.02	0.06
Investment in Securities	37.14	74.01	21.24	-139.62	-169.5	109.06
Other Investing Activities	8.69	11.84	8.5	7.16	4.38	1.98
Investing Cash Flow	-185.15	-155.36	-186.4	-419.43	-375.65	-63.7

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Short-Term Debt Issued	-	-	-	-	-	102
Long-Term Debt Issued	-	81.34	190.23	205.93	392.14	-
Total Debt Issued	61.9	81.34	190.23	205.93	392.14	102
Short-Term Debt Repaid	-	-	-	-	-	-177.33
Long-Term Debt Repaid	-	-70.9	-155.96	-130.69	-304	-
Lease Payments	-4.01	-1.51	-1.08	-	-	-
Total Debt Repaid	-48.69	-70.9	-155.96	-130.69	-304	-177.33
Net Debt Issued (Repaid)	13.21	10.44	34.27	75.24	88.14	-75.33
Issuance of Common Stock	1	1	41.48	14.19	21.02	-
Repurchase of Common Stock	-0.97	-0.97	-43.45	-	-	-
Common Dividends Paid	-164.11	-163.29	-131.99	-63.99	-71.41	-53.98
Other Financing Activities	-40.27	-15.49	-23.9	-34.62	-2.32	-5.01
Financing Cash Flow	-191.14	-168.31	-123.59	-9.18	35.43	-134.32

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	-2.11	1.31	2.96	0.76	1.57	-1.78
Net Cash Flow	48.5	138.24	82.55	-88.04	63.53	129.92

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	195.39	218.73	172.05	52.34	191.62	154.91
Free Cash Flow Growth	-5.90%	27.13%	228.72%	-72.69%	23.70%	-11.36%
Free Cash Flow Margin	11.39%	13.34%	11.47%	4.03%	14.34%	13.31%
Free Cash Flow Per Share	0.38	0.42	0.33	0.10	0.37	0.30
Levered Free Cash Flow	94.47	113.17	106.64	-67.76	62.94	60.55
Unlevered Free Cash Flow	95.71	114.31	108.59	-64.93	64.78	61.85
Free Cash Flow After Leases	191.38	217.23	170.97	52.34	191.62	154.91

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Interest Paid	0.01	-	-	-	-	-
Cash Income Tax Paid	98.39	87.94	73.73	65.82	63.17	79.45
Change in Working Capital	-25.78	44.51	40.55	42.58	125.22	89.35

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error